<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609045/" ref="ordinalpos=1813&amp;ncbi_uid=5662678&amp;link_uid=PMC3609045" image-link="/pmc/articles/PMC3609045/figure/F5/" class="imagepopup">Figure. From: Dysregulation of neural calcium <span class="highlight" style="background-color:">signaling</span> in Alzheimer disease, bipolar disorder and schizophrenia. </a></div><br /><div class="p4l_captionBody"><b>Figure 5.</b> Dysregulation of modulatory Ca2+ signaling pathways contribute to neural diseases. Hypofunction of the NMDA receptor results in a reduction in the gene transcription necessary to maintain the GABAergic phenotype resulting in schizophrenia. Hyperfunction of the Ins(1,4,5)P3/Ca2+ signaling pathway has been linked to both bipolar disorder and Alzheimer disease.</div></div>